Search results
Results from the WOW.Com Content Network
Cancer Prevention Research. Cancer Prev. Res. (Phila.) Cancer Prevention Research is a peer-reviewed medical journal that publishes original studies, reviews, and commentaries in the fields of cancer prevention and interception. It was launched in 2008 by its publisher, the American Association for Cancer Research.
Melanoma Research. Melanoma Research is a bimonthly peer-reviewed medical journal published by Lippincott Williams & Wilkins and the editor-in-chief is F.J. Lejeune. It was established in 1991. The journal covers both experimental and clinical research on melanoma .
The European Journal of Cancer Prevention (print: ISSN 0959-8278, online: ISSN 1473-5709) is the official journal of the European Cancer Prevention Organization. It was established in 1991 and is published bimonthly by Lippincott Williams & Wilkins. The journal focuses on raising awareness of the various forms of cancer prevention as well as ...
Talimogene laherparepvec, sold under the brand name Imlygic among others, is a biopharmaceutical medication used to treat melanoma that cannot be operated on; it is injected directly into a subset of lesions which generates a systemic immune response against the recipient's cancer. [5] The final four year analysis from the pivotal phase 3 study ...
Pigment Cell & Melanoma Research. Pigment Cell & Melanoma Research is a peer-reviewed scientific journal of dermatology. It is the official journal of the International Federation of Pigment Cell Societies (IFPCS) and the Society for Melanoma Research (SMR). In 2014, it ranked the 3rd most cited journal of dermatology, out of 62.
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology.Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in ...
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. As a journal-level metric, it is frequently used as a proxy for ...
In early 2010 a Phase I trial [16] for solid tumors (including colorectal cancer), and a phase II study (for metastatic melanoma) were ongoing. [17] A phase III trial (vs dacarbazine) in patients with previously untreated metastatic melanoma showed an improved rates of overall and progression-free survival. [18]